SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-03-18 23:20 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Science, Health, Property, Asia, South Korea, Economy & Finance, Elections, World News, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
INCHEON, South Korea, March 18, 2026 /PRNewswire/ -- SK bioscience announced on 18 that it has entered into a funding agreement with the Research Investment for Global Health Technology Foundation (RIGHT Foundation) to receive financial support for early clinical development of its RSV (respiratory syncytial virus) preventive monoclonal antibody candidate, RSM01.
--------------------------------------------------------------------